CMS Open Payments · Program Year 2024
Prenosis Inc.
Prenosis Inc. reported $474,513.88 across General Payments, Research, and Ownership to 46 physicians and teaching hospitals across 56 transactions.
- $474.5K
- All-tracks total
- 56
- Transactions
- 46
- Recipients
- #777
- of 1,925 companies
Prenosis Inc. reported $474,513.88 across all CMS Open Payments tracks (General + Research + Ownership) to 46 physicians and teaching hospitals in Program Year 2024 - ranking #777 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $144,477.87, averaging $10.3K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer prenosis-inc Prenosis Inc.
$474.5K · #777/1,925 · 0.0% industry · PY2024
- TOT $474.5K
- RANK #777
- SHARE 0.0%
- TXN 56
- RCP 46
- CAT 3
- GEN $144.5K
- TOP1 87.4%
- PY 2024
Volume peers
Nearest volume peer: Cardinal Health 414 LLC ($474.5K)
Prenosis Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Prenosis Inc.
$474,513.88: that is what Prenosis Inc. reported in payments to 46 physicians and teaching hospitals during Program Year 2024, spread across 56 transactions ($8.5K per transaction, $10.3K per recipient). The company sits at rank #777 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $142.6K across 36 transactions, 98.7% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Prenosis Inc. made 3 types of general payments. "Consulting Fee" is the largest category at $142.6K, 98.7% of General Payments.
How Prenosis Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $142.6K | 36 | 98.7% |
| Travel and Lodging | $1.7K | 4 | 1.2% |
| Food and Beverage | $190.18 | 6 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $138,827.07 (96.1%) of $144,477.87 in this company's General Payments records across 23 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Prenosis Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Nathan Shapiro
$126,228.45 across 16 reported transactions
- 2
Sean Collins
$9,401.02 across 8 reported transactions
- 3
Farhan Ali
$1,980.00 across 1 reported transactions
- 4
Kevin Klauer
$742.60 across 1 reported transactions
- 5
William Brad Weir
$475.00 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Prenosis Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Prenosis Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Prenosis Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Sixth Street Solutions, LLC
Monteris Medical Corporation
HEMA Biologics, LLC
ImClone Systems, LLC
Gentuity, LLC
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.